Arrail Group Limited (6639.HK)

HKD 2.8

(-0.71%)

EBITDA Summary of Arrail Group Limited

  • Arrail Group Limited's latest annual EBITDA in 2023 was 322.34 Million CNY , up 381.08% from previous year.
  • Arrail Group Limited's latest quarterly EBITDA in 2023 FY was N/A , up 381.08% from previous quarter.
  • Arrail Group Limited reported an annual EBITDA of 87.84 Million CNY in 2022, down -353.81% from previous year.
  • Arrail Group Limited reported an annual EBITDA of 42.1 Million CNY in 2021, down -79.7% from previous year.
  • Arrail Group Limited reported a quarterly EBITDA of 61.64 Million CNY for 2023 Q2, up 134.66% from previous quarter.
  • Arrail Group Limited reported a quarterly EBITDA of N/A for 2023 FY, up 381.08% from previous quarter.

Annual EBITDA Chart of Arrail Group Limited (2023 - 2018)

Historical Annual EBITDA of Arrail Group Limited (2023 - 2018)

Year EBITDA EBITDA Growth
2023 322.34 Million CNY 381.08%
2022 87.84 Million CNY -353.81%
2021 42.1 Million CNY -79.7%
2020 207.43 Million CNY 79.46%
2019 -32.34 Million CNY 2.83%
2018 112.4 Million CNY 0.0%

Peer EBITDA Comparison of Arrail Group Limited

Name EBITDA EBITDA Difference
Aidigong Maternal & Child Health Limited 68.84 Million HKD -368.2%
UMP Healthcare Holdings Limited 161.98 Million HKD -99.001%
Human Health Holdings Limited 104.06 Million HKD -209.757%
EuroEyes International Eye Clinic Limited 292.1 Million HKD -10.353%
Kato (Hong Kong) Holdings Limited 133.61 Million HKD -141.257%
Bamboos Health Care Holdings Limited 52.75 Million HKD -510.99%
Beijing Health (Holdings) Limited -44.19 Million HKD 829.438%
C-MER Eye Care Holdings Limited 359.88 Million HKD 10.43%
Town Health International Medical Group Limited 53.5 Million HKD -502.505%
Medicskin Holdings Limited 6.77 Million HKD -4657.172%
Hang Chi Holdings Limited 81.58 Million HKD -295.095%